Valtteri Kaasinen

7.0k total citations
141 papers, 4.7k citations indexed

About

Valtteri Kaasinen is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Valtteri Kaasinen has authored 141 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Neurology, 44 papers in Cellular and Molecular Neuroscience and 33 papers in Cognitive Neuroscience. Recurrent topics in Valtteri Kaasinen's work include Parkinson's Disease Mechanisms and Treatments (82 papers), Neurological disorders and treatments (74 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). Valtteri Kaasinen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (82 papers), Neurological disorders and treatments (74 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). Valtteri Kaasinen collaborates with scholars based in Finland, United States and United Kingdom. Valtteri Kaasinen's co-authors include Juha O. Rinne, Juho Joutsa, Kjell Någren, Tero Vahlberg, Jörgen Bergman, Jarmo Hietala, Jarkko Johansson, Maria Gardberg, Pirkko Sonninen and Riitta Parkkola and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and NeuroImage.

In The Last Decade

Valtteri Kaasinen

134 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valtteri Kaasinen Finland 40 2.2k 1.5k 1.3k 711 594 141 4.7k
Tamara Hershey United States 50 1.6k 0.8× 1.0k 0.7× 1.4k 1.0× 779 1.1× 561 0.9× 166 7.2k
Thilo van Eimeren Germany 38 2.9k 1.3× 1.2k 0.8× 1.7k 1.3× 635 0.9× 620 1.0× 139 4.9k
Olivier Blin France 38 1.8k 0.8× 1.0k 0.7× 1.2k 0.9× 370 0.5× 455 0.8× 170 4.9k
Raúl de la Fuente‐Fernández Canada 39 3.6k 1.7× 2.0k 1.3× 1.7k 1.3× 576 0.8× 215 0.4× 88 5.6k
Patrick Santens Belgium 36 1.6k 0.7× 591 0.4× 1.2k 0.9× 907 1.3× 308 0.5× 180 4.1k
Edward D. Huey United States 35 1.7k 0.8× 650 0.4× 1.6k 1.2× 1.1k 1.6× 397 0.7× 156 4.8k
P. Simon Jones United Kingdom 37 1.0k 0.5× 985 0.7× 1.7k 1.3× 797 1.1× 283 0.5× 82 4.4k
Christopher G. Goetz United States 33 4.1k 1.9× 1.6k 1.1× 909 0.7× 892 1.3× 687 1.2× 102 6.3k
Hiroaki Kazui Japan 39 1.9k 0.9× 2.1k 1.4× 1.7k 1.3× 941 1.3× 247 0.4× 194 6.1k
Young T. Hong United Kingdom 35 1.1k 0.5× 1.4k 0.9× 1.4k 1.0× 1.1k 1.5× 242 0.4× 101 4.7k

Countries citing papers authored by Valtteri Kaasinen

Since Specialization
Citations

This map shows the geographic impact of Valtteri Kaasinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valtteri Kaasinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valtteri Kaasinen more than expected).

Fields of papers citing papers by Valtteri Kaasinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valtteri Kaasinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valtteri Kaasinen. The network helps show where Valtteri Kaasinen may publish in the future.

Co-authorship network of co-authors of Valtteri Kaasinen

This figure shows the co-authorship network connecting the top 25 collaborators of Valtteri Kaasinen. A scholar is included among the top collaborators of Valtteri Kaasinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valtteri Kaasinen. Valtteri Kaasinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koponen, Marjaana, et al.. (2025). Bipolar Disorder as a Long‐Term Risk Factor for Parkinson's Disease: A Nationwide Case–Control Study. Movement Disorders. 41(3). 690–698. 1 indexed citations
2.
Kaasinen, Valtteri, et al.. (2025). Impact of Parkinson's disease diagnosis validity on the association with cancer: A systematic review and meta-analysis. Parkinsonism & Related Disorders. 135. 107846–107846.
3.
Vahlberg, Tero, Maria Gardberg, Tommi Noponen, et al.. (2025). Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years. Neurology. 104(9). e213499–e213499.
4.
Sun, Lihua, Jouni Tuisku, Valtteri Kaasinen, et al.. (2024). Seasonal variation in D2/3 dopamine receptor availability in the human brain. European Journal of Nuclear Medicine and Molecular Imaging. 51(11). 3284–3291. 2 indexed citations
5.
Brolin, Kajsa, Eva Schaeffer, Artur Francisco Schumacher Schuh, et al.. (2024). Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications. Movement Disorders. 40(2). 204–221. 13 indexed citations
6.
Sipilä, Jussi, et al.. (2023). A severe neurodegenerative disease with Lewy bodies and a mutation in the glucocerebrosidase gene. npj Parkinson s Disease. 9(1). 53–53. 4 indexed citations
7.
Mertsalmi, Tuomas, et al.. (2023). Floating door sign does not differentiate Parkinson’s disease from essential tremor. Clinical Parkinsonism & Related Disorders. 8. 100184–100184.
8.
Joutsa, Juho, Tero Vahlberg, Tommi Noponen, et al.. (2022). Diagnostic value of micrographia in Parkinson’s disease: a study with [123I]FP-CIT SPECT. Journal of Neural Transmission. 129(7). 895–904. 7 indexed citations
9.
Kaasinen, Valtteri, Tero Vahlberg, A. Jon Stoessl, Antonio P. Strafella, & Angelo Antonini. (2021). Dopamine Receptors in Parkinson's Disease: A Meta‐Analysis of Imaging Studies. Movement Disorders. 36(8). 1781–1791. 57 indexed citations
10.
Tuominen, Jarno, Sakari Kallio, Valtteri Kaasinen, & Henry Railo. (2021). Segregated brain state during hypnosis. Neuroscience of Consciousness. 2021(1). niab002–niab002. 11 indexed citations
11.
Kantonen, Tatu, Tomi Karjalainen, Janne Isojärvi, et al.. (2020). Interindividual variability and lateralization of μ-opioid receptors in the human brain. NeuroImage. 217. 116922–116922. 66 indexed citations
12.
Hartikainen, Sirpa, et al.. (2020). Parkinsonin taudin lääkkeiden erityiskorvausoikeuden saajien määrän muutos vuosina 1996-2015. UEF eRepo (University of Eastern Finland). 1 indexed citations
13.
Railo, Henry, et al.. (2018). Dopamine and eye movement control in Parkinson’s disease: deficits in corollary discharge signals?. PeerJ. 6. e6038–e6038. 10 indexed citations
14.
Kaasinen, Valtteri, et al.. (2014). Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 41(10). 1931–1937. 46 indexed citations
15.
Joutsa, Juho, Juha O. Rinne, Olli Eskola, & Valtteri Kaasinen. (2013). Reduced Striatal Dopamine Synthesis Capacity is Associated with Symptoms of Depression in Patients with de novo Unmedicated Parkinson's Disease. Journal of Parkinson s Disease. 3(3). 325–329. 13 indexed citations
16.
Joutsa, Juho, Kirsti Martikainen, Tero Vahlberg, & Valtteri Kaasinen. (2012). Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. Parkinsonism & Related Disorders. 18(10). 1079–1083. 42 indexed citations
17.
Joutsa, Juho, Kirsti Martikainen, Tero Vahlberg, Valerie Voon, & Valtteri Kaasinen. (2011). Impulse control disorders and depression in Finnish patients with Parkinson's disease. Parkinsonism & Related Disorders. 18(2). 155–160. 94 indexed citations
18.
Kuoppamäki, Mikko, Reijo J. Marttila, Valtteri Kaasinen, et al.. (2009). Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily. European Journal of Clinical Pharmacology. 65(5). 443–455. 68 indexed citations
19.
Kaasinen, Valtteri, R. P. Maguire, Hans‐Peter Hundemer, & Klaus L. Leenders. (2005). Corticostriatal covariance patterns of 6–[18F]fluoro–L–dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease. Journal of Neurology. 253(3). 340–348. 13 indexed citations
20.
Kaasinen, Valtteri, Sargo Aalto, Kjell Någren, & Juha O. Rinne. (2004). Dopaminergic effects of caffeine in the human striatum and thalamus. Neuroreport. 15(2). 281–285. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamara Hershey Breakdown of academic impact, for papers by Thilo van Eimeren Breakdown of academic impact, for papers by Olivier Blin Breakdown of academic impact, for papers by Raúl de la Fuente‐Fernández Breakdown of academic impact, for papers by Patrick Santens Breakdown of academic impact, for papers by Edward D. Huey Breakdown of academic impact, for papers by P. Simon Jones Breakdown of academic impact, for papers by Christopher G. Goetz Breakdown of academic impact, for papers by Hiroaki Kazui Breakdown of academic impact, for papers by Young T. Hong
Rankless by CCL
2026